Search Results 1441-1450 of 17459 for corticosteroid
Participants with previously treated and clinically stable brain/CNS metastases who are receiving concomitant corticosteroids must be on a stable or ...
Patients requiring corticosteroids who have not been on a stable or decreasing dose of corticosteroid for the 7 days prior to enrollment are not eligible ...
Patients requiring daily corticosteroids at a prednisone equivalent of ≥ 20 mg daily should not be enrolled. If corticosteroids can be discontinued (or ...
prednisone, opiates, baclofen, gabapentin, pregabalin, thalidomide, amitriptyline, inhaled corticosteroids, or inhaled bronchodilators. Use of ACE ...
Intermittent topical, inhaled, or intranasal corticosteroids are allowed. Presence of active infection within 72 hours prior to leukapheresis or ...
Regular asthma medications may fail to relieve asthma symptoms associated with a cold or the flu. Also, asthma symptoms caused by a respiratory infection may ...
However, to lessen the tissue inflammation surrounding the brain lesion, Devender's medical team recommended he begin taking corticosteroids. "There was a ...
... corticosteroids, or biologic agents) for any underlying respiratory condition must be on a stable dose for ≥ 30 days prior to randomization. Exclusion ...
... corticosteroids (>10 mg/day prednisone or equivalent), androgens, or androgen reducing agents, systemic beta agonists or beta blockers, and relevant herbal ...
Tolcapone is used in combination with levodopa and carbidopa for the treatment of the symptoms of Parkinson's disease. This medicine is available only with your ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.